BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7279697)

  • 41. Histopathological study of invasive ductal carcinoma (IDC) of the pancreas without associated cancerous occlusion of the main pancreatic duct.
    Naito Y; Suda K; Nobukawa B; Kinoshita H; Kojiro M
    J Hepatobiliary Pancreat Surg; 2006; 13(6):556-61. PubMed ID: 17139431
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis.
    Gold DV; Modrak DE; Ying Z; Cardillo TM; Sharkey RM; Goldenberg DM
    J Clin Oncol; 2006 Jan; 24(2):252-8. PubMed ID: 16344318
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Diagnostic value of serum Ca 19-9 antigen in chronic pancreatitis and pancreatic adenocarcinoma].
    Nouts A; Lévy P; Voitot H; Bernades P
    Gastroenterol Clin Biol; 1998 Feb; 22(2):152-9. PubMed ID: 9762189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The two stage provocative test for pancreatic disease by serum enzyme measurements.
    Kim DK; Schwartz MK; Sherlock P
    Surg Gynecol Obstet; 1980 Jan; 150(1):49-53. PubMed ID: 7350701
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CA 50 compared with CA 19-9 as a serum tumour marker for pancreatic carcinoma.
    Pasquali C; Sperti C; D'Andrea AA; Costantino V; Filipponi C; Pedrazzoli S
    Ital J Gastroenterol; 1994 May; 26(4):169-73. PubMed ID: 7949259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer.
    Hong SH; Misek DE; Wang H; Puravs E; Giordano TJ; Greenson JK; Brenner DE; Simeone DM; Logsdon CD; Hanash SM
    Cancer Res; 2004 Aug; 64(15):5504-10. PubMed ID: 15289361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma.
    Zhang L; Sanderson SO; Lloyd RV; Smyrk TC
    Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Focal pancreatic mass: distinction of pancreatic cancer from chronic pancreatitis using gadolinium-enhanced 3D-gradient-echo MRI.
    Kim JK; Altun E; Elias J; Pamuklar E; Rivero H; Semelka RC
    J Magn Reson Imaging; 2007 Aug; 26(2):313-22. PubMed ID: 17610286
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of pancreas-specific antigen in immunodiagnosis of pancreatic cancer.
    Loor R; Nowak NJ; Manzo ML; Douglass HO; Chu TM
    Clin Lab Med; 1982 Sep; 2(3):567-78. PubMed ID: 6754226
    [No Abstract]   [Full Text] [Related]  

  • 50. Serum CA 242 in pancreatic cancer. Comparison with CA 19-9 and CEA.
    Pezzilli R; Billi P; Plate L; Laudadio MA; Sprovieri G
    Ital J Gastroenterol; 1995; 27(6):296-9. PubMed ID: 8562994
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epithelial anomalies in chronic pancreatitis as a risk factor of pancreatic cancer.
    Cylwik B; Nowak HF; Puchalski Z; Barczyk J
    Hepatogastroenterology; 1998; 45(20):528-32. PubMed ID: 9638443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Significance of K-ras codon 12 point mutation in pancreatic juice in the diagnosis of carcinoma of the pancreas.
    Kimura W; Zhao B; Futakawa N; Muto T; Makuuchi M
    Hepatogastroenterology; 1999; 46(25):532-9. PubMed ID: 10228857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antinuclear and pancreatic acinar cell antibodies in pancreatic diseases.
    Lankisch PG; Koop H; Seelig R; Seelig HP
    Digestion; 1981; 21(2):65-8. PubMed ID: 6971769
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proceedings: Antibodies reacting with human exocrine pancreas.
    Lendrum R; Walker G
    Gut; 1975 May; 16(5):405. PubMed ID: 1095454
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunologic studies on a pancreatic oncofetal protein.
    Mihas AA
    J Natl Cancer Inst; 1978 Jun; 60(6):1439-44. PubMed ID: 650707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Autoimmune manifestations in pancreatic diseases].
    Protsenko VA
    Klin Med (Mosk); 1974 Feb; 52(2):23-5. PubMed ID: 4466908
    [No Abstract]   [Full Text] [Related]  

  • 57. Antibody mediated injury to pancreas & susceptibility to infections.
    Sarda S; Gupta KG
    Indian J Exp Biol; 1975 Nov; 13(6):527-31. PubMed ID: 1218919
    [No Abstract]   [Full Text] [Related]  

  • 58. Purification and characterization of a pancreatic cancer-associated antigen (PCAA) from normal colonic mucosa.
    Shimano T; Mori T; Kitada M; Maruyama H; Kosaki G
    Ann N Y Acad Sci; 1983; 417():97-104. PubMed ID: 6422827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Two pancreas "tissue-specific" antigens in normal human urine, one being and esterase.
    Greene EL; Halbert SP; Kiefer D
    Int Arch Allergy Appl Immunol; 1975; 48(6):764-75. PubMed ID: 806537
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Organ proteins of the pancreas].
    Friemel H; Mücke D; Gülzow M
    Acta Biol Med Ger; 1967; 19(2):343-4. PubMed ID: 5627256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.